A possible explanation for the difference in survival of truncating TP53 mutations or missense TP53 mutations is that the mutated p53 protein may still execute some of its tumor-suppressive functions in metastatic PCa (6). This evidence concerns the gene TP53 and posterior cortical atrophy.